Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2020 | PARACHUTE trial: ATG in HCST

Jaap Jan Boelens • 1 Sep 2020
EBMT 2020
General Anti-thymocyte globulin
PARACHUTE

Jaap Jan Boelens, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, discusses the PARACHUTE-trial (NTR4960), involving anti-thymocyte globulin (ATG) introduction into the conditioning regimen in hematopoietic stem cell transplantation (HSCT) to prevent graft-versus-host-disease. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Jaap Jan Boelens

Gene therapy as the standard of care for patients with SCD who lack a matched sibling donor
2:05
Gene therapy as the standard of care for patients with SCD who lack a matched sibling donor
Jaap Jan Boelens • 6 Sep 2024
Navigating U.S. healthcare insurance when treating patients with SCD
1:44
Navigating U.S. healthcare insurance when treating patients with SCD
Jaap Jan Boelens • 6 Sep 2024
The need for up-to-date and evidence-based data for the use of DLIs in SCD
2:22
The need for up-to-date and evidence-based data for the use of DLIs in SCD
Jaap Jan Boelens • 6 Sep 2024
The SCD treatment landscape: preventive medicine, disease-modifying agents, and curative approaches
1:21
The SCD treatment landscape: preventive medicine, disease-modifying agents, and curative approaches
Jaap Jan Boelens • 6 Sep 2024

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals